Quaker Chemical Corporati... (KWR)
101.60
0.69 (0.68%)
At close: Apr 17, 2025, 3:59 PM
100.85
-0.74%
Pre-market: Apr 21, 2025, 05:49 AM EDT
Quaker Chemical Revenue Breakdown
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
|---|---|---|---|---|---|---|---|
| Global Specialty Businesses Revenue | 98.47M | 101.09M | 96.76M | 90.11M | 83.87M | 77.37M | 80.59M |
| Global Specialty Businesses Revenue Growth | -2.60% | +4.48% | +7.38% | +7.44% | +8.40% | -4.00% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|
| Americas Revenue | 9.3M | 9.01M | 696.1M | 572.64M | 450.16M | 541.55M | 134.4M |
| Americas Revenue Growth | +3.28% | -98.71% | +21.56% | +27.21% | -16.88% | +302.95% | n/a |
| Asia Pacific Revenue | 6.4M | 2.65M | 386.45M | 388.16M | 315.3M | 276.27M | 102.42M |
| Asia Pacific Revenue Growth | +141.31% | -99.31% | -0.44% | +23.11% | +14.13% | +169.75% | n/a |
| Emea Revenue | 19.78M | 24.86M | 474.6M | 480.13M | 383.19M | 315.69M | n/a |
| Emea Revenue Growth | -20.45% | -94.76% | -1.15% | +25.30% | +21.38% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 125.44M | 118.22M | 102.2M | 109.71M | 106.88M | 122.81M | 119.85M | 119.55M | 112.33M | 115.46M | 115.83M | 111.8M | 101.65M | 104.22M | 108.68M | 104.31M | 98.35M | 97.04M | 86.67M | 98.7M | 101.53M | 80.81M | 50.03M | 51.45M | 50.51M | 53.27M | 54.08M | 50.01M | 50.07M | 51.09M | 49.59M | 48.05M | 49.76M | 49.44M | 49.14M | 48.64M | 48.75M | 52.6M | 49.17M | 48.46M |
| Selling, General, and Administrative Revenue Growth | +6.11% | +15.67% | -6.84% | +2.64% | -12.97% | +2.47% | +0.25% | +6.43% | -2.71% | -0.32% | +3.61% | +9.98% | -2.46% | -4.11% | +4.19% | +6.06% | +1.35% | +11.97% | -12.19% | -2.79% | +25.64% | +61.54% | -2.78% | +1.86% | -5.18% | -1.50% | +8.15% | -0.13% | -1.99% | +3.02% | +3.20% | -3.42% | +0.64% | +0.61% | +1.03% | -0.23% | -7.32% | +6.97% | +1.46% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | 50.3M | n/a | n/a | n/a | 46M | n/a | n/a | n/a | 44.9M | n/a | n/a | n/a | 40M | n/a | n/a | n/a | 32.1M | n/a | n/a | n/a | 24.5M | n/a | n/a | n/a | 23.9M | n/a | n/a | n/a | 22.5M | n/a | n/a | n/a | 22.1M | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a |